Showing results (371-380 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|October 3, 2006
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypesFarshad Guirakhoo, Scott Kitchener, Dennis Morrison, et al.Human Vaccines|October 3, 2006
Safety and immunogenicity of a meningococcal (Groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine in healthy children aged 2 to 10 years in ChileRosanna Lagos, Thomas Papa, Alma Muñoz, et al.Human Vaccines|October 3, 2006
Active specific immunotherapy with autologous tumor cell vaccines for stage II colon cancer: logistics, efficacy, safety and immunological PharmacodynamicsMichael G Hanna, Herbert C Hoover, H M Pinedo, et al.Human Vaccines|October 3, 2006
Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and WalesCaroline L Trotter, W John Edmunds, Mary E Ramsay, et al.Human Vaccines|October 3, 2006
Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), ChileRosanna M Lagos, Alma E Muñoz, Myron M LevineHuman Vaccines|October 3, 2006
Bell's palsy and parenteral inactivated influenza vaccineJulia Stowe, Nick Andrews, Lesley Wise, et al.Human Vaccines|October 14, 2006
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infectionGeert Leroux-Roels, Arsène-Hélène Batens, Isabelle Desombere, et al.Human Vaccines|October 14, 2006
Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometryCaroline Vipond, Jun X Wheeler, Christopher Jones, et al.Human Vaccines|January 25, 2007
Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of ageMonia Marchetti, Ursula M Kühnel, Giorgio L Colombo, et al.Human Vaccines|April 4, 2007
The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infantsRoman Prymula, Marie-Pierre David, Inge Lefevre, et al.Pageof 64